Treatment of glaucoma using endothelin receptor antagonists | Patent Publication Number 20220257568
US 20220257568 A1Patent NumberUS 11738007 B2
Application Number17733216
Filled DateApr 29, 2022
Priority DateOct 30, 2019
Publication DateAug 18, 2022
Original AssigneePerfuse Therapeutics Inc.
Current AssigneePerfuse Therapeutics Inc.
Inventor/ApplicantsSevgi Gurkan
David Floyd
David Floyd
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.